LYONS GARY A Insider Trading -- Recent SEC Form 4 Transactions
LYONS GARY A (CIK 1123343) reported 18 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-11-19). Recent activity: Sell NBIX (1,200 shares), Sell NBIX (4,011 shares), Sell NBIX (5,689 shares), Sell NBIX (4,100 shares), Buy NBIX (15,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-19 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 1,200 | $195,733 |
| 2026-11-19 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 4,011 | $657,555 |
| 2026-11-19 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 5,689 | $939,565 |
| 2026-11-19 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 4,100 | $680,177 |
| 2026-11-19 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 15,000 | $804,600 |
| 2026-08-19 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 5,000 | $87,200 |
| 2026-08-19 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 1,900 | $118,807 |
| 2026-08-19 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 2,600 | $165,100 |
| 2026-08-19 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 500 | $32,080 |
| 2026-08-19 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 5,000 | $87,200 |
| 2026-08-19 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 4,100 | $259,407 |
| 2026-08-19 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 900 | $57,474 |
| 2026-05-21 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 1,659 | $0 |
| 2026-05-21 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 4,000 | $0 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 8,000 | $130,640 |
| 2026-04-16 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 8,000 | $328,560 |
| 2025-12-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Buy | 15,000 | $718,350 |
| 2025-12-04 | NEUROCRINE BIOSCIENCES INC (NBIX) | Director | Sell | 15,000 | $2.3M |
Source: SEC Form 4 filings · as of 2026-11-19